缺陷累积衰弱指数在ASPREE研究中的验证及对无残疾生存的预测能力
在ASPREE临床试验19 110名无痴呆、心血管疾病和重大躯体残疾的65-98岁社区居住者中,验证67项缺陷累积衰弱指数(FI)。FI与步速和握力负相关,与改良Fried衰弱表型强相关,且能独立预测无重大残疾和痴呆的独立生活复合结局及持续性躯体残疾。
要点
- FI在年龄、性别和种族基础上显著提升对无残疾生存的预测能力。
核心结论
- 缺陷累积衰弱指数是相对健康老年人的有用衰老生物标志物,可提供个体脆弱性和疾病风险信息。
研究设计与样本
- 在ASPREE临床试验的19 110名65-98岁社区居住者中表征67项缺陷累积衰弱指数(FI),参与者来自美国和澳大利亚,无痴呆、心血管疾病和重大躯体残疾。
主要发现
- FI与年龄正相关,女性在所有年龄段的FI均显著高于男性。
- 衰弱与无重大残疾和痴呆的独立生活复合结局相关,并增加持续性躯体残疾发生率(HR 21.3,95%CI 15.6-28.9)。
- FI在年龄、性别和种族基础上显著提升对这些结局的预测能力。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Frailty is a state of heightened vulnerability and susceptibility to physiologic stressors that increases with age. It has shown increasing utility in predicting a range of adverse health outcomes. Here, we characterize a 67-item deficit-accumulation frailty index (FI) in 19 110 community-dwelling individuals in the ASPirin in Reducing Events in the Elderly clinical trial. Participants aged 65-98 years were recruited from the United States and Australia and were without diagnosed dementia and cardiovascular disease, and major physical disability. The median FI score was .10 (interquartile range: .07-.14) at baseline, and the prevalence of frailty (FI > .21) increased from 8.1% to 17.4% after 6 years. FI was positively associated with age, and women had significantly higher scores than men at all ages. The FI was negatively correlated with gait speed (r = -.31) and grip strength (r = -.46), and strongly associated with a modified Fried's frailty phenotype (p < .0001, for all comparisons). Frailty was associated with the primary composite outcome capturing independent life lived free of major disability and dementia, and increased the rate of persistent physical disability (hazard ratio: 21.3, 95% confidence interval: 15.6-28.9). It added significantly to the predictive capacity of these outcomes above age, sex, and ethnicity alone. The FI is thus a useful biomarker of aging even among relatively healthy older individuals and provides important information about an individual's vulnerability to and risk of disease.
引用
- Ryan J, Espinoza S, Ernst ME, et al. Validation of a Deficit-Accumulation Frailty Index in the ASPirin in Reducing Events in the Elderly Study and Its Predictive Capacity for Disability-Free Survival. J Gerontol A Biol Sci Med Sci. 2022. PMID: 34338761. doi:10.1093/gerona/glab225
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。